Opportunity: That was the thing that I first noted. IMA is buying up every other company but only licensing from BOCX. Apparently we're not for sale. A license is the best they can do and they said "okay". So Bocx definitely has something they think is very valuable if they will be happy with just the deal.
I agree that Inverness did not put the item on their website because they do not want attention drawn to BOCX. As to Dr. Moro selling BioCurex, I would have only one comment. It is patient first, investor second. If a buyout would speed his development of cancer therapy, he will do it in the blink of an eye. I personally think he is a free thinker and I doubt if he would want anyone telling him what he should work on so it would depend upon what kind of deal could be worked out in the patients best interest.
News 
Market Data 
Discover 
AI
